These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34176369)

  • 1. Validating ADME QSAR Models Using Marketed Drugs.
    Siramshetty V; Williams J; Nguyễn ÐT; Neyra J; Southall N; Mathé E; Xu X; Shah P
    SLAS Discov; 2021 Dec; 26(10):1326-1336. PubMed ID: 34176369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
    Siramshetty VB; Shah P; Kerns E; Nguyen K; Yu KR; Kabir M; Williams J; Neyra J; Southall N; Nguyễn ÐT; Xu X
    Sci Rep; 2020 Nov; 10(1):20713. PubMed ID: 33244000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using in vitro ADME data for lead compound selection: An emphasis on PAMPA pH 5 permeability and oral bioavailability.
    Williams J; Siramshetty V; Nguyễn ÐT; Padilha EC; Kabir M; Yu KR; Wang AQ; Zhao T; Itkin M; Shinn P; Mathé EA; Xu X; Shah P
    Bioorg Med Chem; 2022 Feb; 56():116588. PubMed ID: 35030421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of PAMPA-BBB QSAR model to predict brain penetration potential of novel drug candidates.
    Kato R; Zeng W; Siramshetty VB; Williams J; Kabir M; Hagen N; Padilha EC; Wang AQ; Mathé EA; Xu X; Shah P
    Front Pharmacol; 2023; 14():1291246. PubMed ID: 38108064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of an ADME enabling selection and visualization tool for drug discovery.
    Stoner CL; Gifford E; Stankovic C; Lepsy CS; Brodfuehrer J; Prasad JV; Surendran N
    J Pharm Sci; 2004 May; 93(5):1131-41. PubMed ID: 15067690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring NCATS in-house biomedical data for evidence-based drug repurposing.
    Liu F; Patt A; Chen C; Huang R; Xu Y; Mathé EA; Zhu Q
    PLoS One; 2024; 19(1):e0289518. PubMed ID: 38271343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-silico ADME models: a general assessment of their utility in drug discovery applications.
    Gleeson MP; Hersey A; Hannongbua S
    Curr Top Med Chem; 2011; 11(4):358-81. PubMed ID: 21320065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-ADME relationship: still a long way to go?
    Hou T; Wang J
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):759-70. PubMed ID: 18611116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critically Assessing the Predictive Power of QSAR Models for Human Liver Microsomal Stability.
    Liu R; Schyman P; Wallqvist A
    J Chem Inf Model; 2015 Aug; 55(8):1566-75. PubMed ID: 26170251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico ADME/T modelling for rational drug design.
    Wang Y; Xing J; Xu Y; Zhou N; Peng J; Xiong Z; Liu X; Luo X; Luo C; Chen K; Zheng M; Jiang H
    Q Rev Biophys; 2015 Nov; 48(4):488-515. PubMed ID: 26328949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico predictions of ADME-Tox properties: drug absorption.
    Geerts T; Vander Heyden Y
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):339-61. PubMed ID: 21470183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NCATS Inxight Drugs: a comprehensive and curated portal for translational research.
    Siramshetty VB; Grishagin I; Nguyễn ÐT; Peryea T; Skovpen Y; Stroganov O; Katzel D; Sheils T; Jadhav A; Mathé EA; Southall NT
    Nucleic Acids Res; 2022 Jan; 50(D1):D1307-D1316. PubMed ID: 34648031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of QSAR models for microsomal stability: identification of good and bad structural features for rat, human and mouse microsomal stability.
    Hu Y; Unwalla R; Denny RA; Bikker J; Di L; Humblet C
    J Comput Aided Mol Des; 2010 Jan; 24(1):23-35. PubMed ID: 19937264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico approaches for predicting ADME properties of drugs.
    Yamashita F; Hashida M
    Drug Metab Pharmacokinet; 2004 Oct; 19(5):327-38. PubMed ID: 15548844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics Profiler (PhaKinPro): Model Development, Validation, and Implementation as a Web Tool for Triaging Compounds with Undesired Pharmacokinetics Profiles.
    Rath M; Wellnitz J; Martin HJ; Melo-Filho C; Hochuli JE; Silva GM; Beasley JM; Travis M; Sessions ZL; Popov KI; Zakharov AV; Cherkasov A; Alves V; Muratov EN; Tropsha A
    J Med Chem; 2024 Apr; 67(8):6508-6518. PubMed ID: 38568752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADME-Space: a new tool for medicinal chemists to explore ADME properties.
    Bocci G; Carosati E; Vayer P; Arrault A; Lozano S; Cruciani G
    Sci Rep; 2017 Jul; 7(1):6359. PubMed ID: 28743970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Evaluation of Local and Global Machine Learning Models for the Prediction of ADME Properties.
    Di Lascio E; Gerebtzoff G; Rodríguez-Pérez R
    Mol Pharm; 2023 Mar; 20(3):1758-1767. PubMed ID: 36745394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
    Sun H; Shah P; Nguyen K; Yu KR; Kerns E; Kabir M; Wang Y; Xu X
    Bioorg Med Chem; 2019 Jul; 27(14):3110-3114. PubMed ID: 31176566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR and ADME.
    Hansch C; Leo A; Mekapati SB; Kurup A
    Bioorg Med Chem; 2004 Jun; 12(12):3391-400. PubMed ID: 15158808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico ADME-Tox modeling: progress and prospects.
    Alqahtani S
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.